| Literature DB >> 20549365 |
Christian Sohns1, Samuel Sossalla, Dirk Vollmann, Lars Luethje, Joachim Seegers, Jan D Schmitto, Markus Zabel, Silvia Obenauer.
Abstract
The aim of this study was to investigate the prevalence of extracardiac findings diagnosed by 64-multidetector computed tomography (MDCT) examinations prior to circumferential pulmonary vein (PV) ablation of atrial fibrillation (AF). A total of 158 patients (median age, 60.5 years; male 68%) underwent 64-MDCT of the chest and upper abdomen to characterize left atrial and PV anatomy prior to AF ablation. MDCT images were evaluated by a thoracic radiologist and a cardiologist. For additional scan interpretation, bone, lung, and soft tissue window settings were used. CT scans with extra-cardiac abnormalities categorized for the anatomic distribution and divided into two groups: Group 1-exhibiting clinically significant or potentially significant findings, and Group 2-patients with clinically non-significant findings. Extracardiac findings (n = 198) were observed in 113/158 (72%) patients. At least one significant finding was noted in 49/158 patients (31%). Group 1 abnormalities, such as malignancies or pneumonias, were found in 85/198 findings (43%). Group 2 findings, for example mild degenerative spine disease or pleural thickening, were observed in 113/198 findings (72%). 74/198 Extracardiac findings were located in the lung (37%), 35/198 in the mediastinum (18%), 8/198 into the liver (4%) and 81/198 were in other organs (41). There is an appreciable prevalence of prior undiagnosed extracardiac findings detected in patients with AF prior to PV-Isolation by MDCT. Clinically significant or potentially significant findings can be expected in ~40% of patients who undergo cardiac MDCT. Interdisciplinary trained personnel is required to identify and interpret both cardiac and extra cardiac findings.Entities:
Mesh:
Year: 2010 PMID: 20549365 PMCID: PMC3035788 DOI: 10.1007/s10554-010-9653-9
Source DB: PubMed Journal: Int J Cardiovasc Imaging ISSN: 1569-5794 Impact factor: 2.357
Distribution of clinical significant or potentially significant extra cardiac findings (Group 1)
| Clinically significant or potentially significant CT findings | Patients %/[ |
|---|---|
| Mediastinal lymph nodes >10 mm | 9/18 |
| Moderate or severe degenerative spine disease | 6.5/13 |
| Diaphragmatic hernia >2 cm | 5.5/11 |
| Moderate or severe emphysema | 4/8 |
| Liver lesion | 3.5/7 |
| Air space opacity | 2.5/5 |
| Aortic aneurysm >4 cm | 2.5/5 |
| Pleural effusion | 2/4 |
| Ground glass attenuation | 2/4 |
| Pulmonary nodule >4 mm | 2/4 |
| Pulmonary tumor | 1/2 |
| Pericardial effusion | 0.5/1 |
| Splenomegaly | 0.5/1 |
| Epigastrial lymph nodes | 0.5/1 |
| Rib lesion | 0.5/1 |
| Total | 43/85 |
Fig. 1Anatomic distribution of all findings (Other localisations were for example: Spine, ribs, spleen, diaphragma). Group 1 comprised patients with clinically significant or potentially significant findings requiring further workup, and Group 2 comprised patients with clinically non-significant findings
Fig. 258-year-old man with AF. a CT-slice at lung window with illustration of pulmonary nodules and infiltration on the left side. b CT-slice at mediastinal window showing mediastinal lymph nodes > 10 mm
Fig. 361-year-old man with AF. CT-slice at standart window with demonstration of a cystic liver lesion
Fig. 484-year-old man with AF. a CT-slice at lung window with illustration of pulmonary infiltration of unknown dignity. b CT-slice of the upper abdomen with demonstation of multiple liver lesions requiring further evaluation
Fig. 568-year-old man with AF. a, b Incidental finding for spiculated mass into the right upper lobe, histological proven lung cancer
Distribution of clinical non-significant extra cardiac findings (Group 2)
| Clinically non-significant findings | Patients %/[ |
|---|---|
| Mild degenerative spine disease | 31.5/6 |
| Small and linear lung opacity | 8.5/17 |
| Mediastinal.lymph nodes <10 mm | 6/12 |
| Pleural thickening | 5.5/11 |
| Aortic ectasis <4 cm | 3/6 |
| Lipoma | 1/2 |
| Pulmonary nodule <4 mm | 0.5/1 |
| Steatosis hepatis | 0.5/1 |
| Total | 72/113 |